Trial Profile
Clinical study for Apatinib Mesylate Tablets combined with concurrent chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: a prospective, open, exploratory study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Antineoplastics
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 24 Oct 2018 New trial record